Merck CEO Expects Faster Production of Personalized Cancer Vaccine
Merck CEO Rob Davis told CNBC on October 14, 2026, that the roughly six-week process for making Merck and Moderna's personalized cancer vaccine, from tumor sequencing to hospital delivery, should shorten over time.
2newsrooms
2articles
17 hoursrunning
Oct 14first seen
Ask Scout
Scout answers questions about this story using only the coverage below.
Coverage over time
Articles
| Oct 15, 6:50 AM | beckershospitalreview.com | Merck CEO: Cancer vaccine production timeline to shorten |
| Oct 14, 1:20 PM | qz.com | Merck CEO expects personalized cancer vaccine to be made faster over time |